Right to Try in Bahrain
How the right to try pathway operates in Bahrain.
About Right to Try
US federal legislation (2018) providing an alternative pathway to investigational drugs.
How Right to Try works in Bahrain
Bahrain's NHRA accepts named-patient import requests for rare-disease and specialty drugs not registered locally.
Patients in Bahrain seeking access under Right to Try typically follow this flow: a licensed physician in Bahrain issues the prescription and clinical justification, the regulator reviews and authorises, and an authorised operator coordinates import.
Documents required in Bahrain
- Physician prescription and clinical-justification letter.
- Patient identification and consent.
- Country-specific NPP/personal-import form.
- Hospital or clinic attestation where required.
Typical timeline
End-to-end 2-6 weeks in most tier 2 jurisdictions. Cellular and gene therapies may require additional ethics-committee review.